Cinryze - supply shortage

Resolved

C1 inhibitor (human)

Shortage information

The shortage affecting Cinzyze has been resolved and the information and recommendations which were issued during the shortage no longer apply.

Key facts

• Medicines affected:
  Cinryze
• Supply shortage status:
  Resolved
• International non-proprietary name (INN) or common name:
  C1 inhibitor (human)
• Therapeutic area (MESH):
  Angioedemas, Hereditary
• Pharmaceutical forms affected:
  Powder and solvent for intravenous injection
• Strengths affected:
  500 IU
• Availability of alternatives:
  Yes

Key dates

• First published:
  06/08/2018
• Last updated:
  25/06/2020